Jamie Bull

• Re-Launch Rare Disease IV Biologic for Refractory Gout to Nephrologist
• Strategically Identified, Educated and Developed Centers of Excellence within multiple markets throughout CO
• Effectively Coordinated and Executed 33 programs, Achieved 23 New/Returning Writers in 2023.
• Top patient enrollment in Region Q1 2024

MVP Award 2023

• Re-Launch First in Class Rare Disease Therapy for Sickle Cell Anemia
• Effectively leveraged relationships between Hematology/Medical Oncology/Community Based Organizations
• Ranked 14th in Nation

• Effectively developed/executed launch of potassium binder indicated for hyperkalemia
• Identified hospital requestors/P&T committee members
• Educated/Supported Patient Access through Specialty Pharmacies, Foundational Support and Market Access pull-through with a white-glove, concierge approach
• Strong scientific, clinical and relational focus, with strategic business approach.
• #1 in Region and 6th/124 in Nation for Trialists, #1 in Nation for MktShare. Grew territory by 131% during Covid.

Field Based Regional Trainer, 2021

Secured University of Colorado Formulary Access, 2021

Secured Cheyenne Medical Center Formulary Access, 2021

Secured Kaiser Colorado Formulary Access, 2019

• Actively partnered with Large Dialysis Organizations(LDOs): Fresenius and DaVita. Worked with C-Suite within LDO’s to ensure optimal Bone Mineral and Anemia goals were achieved across the region.
• Provided clinical education to improve patient outcomes/protocol management.
• Routinely provided educational reimbursement programs educating across all channels within Davita/FMC in subject matters surrounding: Patient Access, Medicare B and D, as well as Foundational Support.
• Proactively participated in the negotiation/management of biologic injectable and contracting with hospitals/clinics.
• Ranked in top 1/3 of nation YOY.

Promoted to ACT II Level Representative, 2015

Amgen Women Interactive Network (AWIN) Member, 2015, 2014

District Sales Trainer/Nephrology, 2015, 2014

District Value Access Lead, 2015, 2014 & Home Office Guest Trainer, 2014

• Provided reimbursement ‘Buy and Bill’ support for biologic skin substitute device covering 6 representatives/7 states.
• Educated customers on proper coding methods, patient support programs and participated in EOB reconciliations.

• Strategically reintroduced mature product lines and identified KOLs.

Best Performing Team Award, 2012

Spirit Award, 2012

GSK 360 Champion, 2012

• Identified/Educated/Developed Accounts imperative for successful launch of uniquely delivered opioid for breakthrough cancer pain management coupled with simultaneous launch of antiemetic for CINV.
• Identified/Certified providers, as well as patients, for access to medication through Specialty Pharmacy Hub/REMS program.
• Worked closely with cancer centers to establish pain protocols with local pain specialists. Ranked Top 10% in nation.

Spearheaded establishment of Fred Hutchinson Cancer Center/SSCA Specialty Pharmacy for Opioid, 2010

• Implemented sales strategies while managing multi-state territory.
• Accountable for re-launching ‘Buy and Bill’ biologic injectable in competitive environment while simultaneously growing topical in Allergy and Dermatology market.
• Facilitated Specialty Hub support for new patients, denied claims and access to medications.
• Ranked top 10% in nation.

• Developed concrete understanding of cutting-edge trends/products, while successfully promoting aligned Specialty portfolio: Urology, Neurology, Allergy, Orthopedic and Women’s Health

Vice President’s Club winner, 2005

District Representative of the Year, 2005

Ranked #1 Representative in District and Region, 2005

Representative of the Quarter, 2005

District Fast Break Award, 2004

• Achieved all sales objectives, and developed plans to maximum business growth/market dominance.
• Developed solid knowledge of reimbursement/’buy and bill’ for injectables, and extended support for denials/reimbursement

Ranked #1 in nation with newly launched injectable, 2001